Cyclin D1/Bcl-1, Human : Trial Size
Code No: MD-17-3S
Background:
Cyclin D1, also known as Bcl-1, CCND1, or PRAD1, is a 36 kDa nuclear protein that plays a key regulatory role during the G1 phase of the cell cycle by regulating the activity of Cdk proteins. Cyclin D1 forms a complex with Cdk4, then binds to and phosphorylates Rb protein, triggering cells to progress from G0/G1 to S and thus driving cellular proliferation. Cyclin D1 protein overexpression is found in the majority of human breast cancers and is usually linked with poor prognosis. Overexpression of cyclin D1 is a well-established criterion for the diagnosis of Mantle Cell Lymphoma, and also has been used to distinguish malignant breast carcinomas from premalignant breast lesions.
Product Type:
Primary Antibody
References:
1) Tokugawa, T., et al., Cancer Res. 62, 4938-4944 (2002)
2) Inagaki, H., et al., Am. J. Pathol. 160, 1435-1443 (2002)
3) Kumazawa, Y., et al., Mol. Pathol. 55, 61-64 (2002)
4) Igarashi, T., et al., Ann. Onc. 13, 928-943 (2002)
5) Chung, D. C., et al., J. Clin. Endocrinol. Metab. 85, 4373-4378 (2000)
6) Imanishi, Y., et al., J. Clin. Invest. 107, 1093-1102 (2001)
7) Jensen, S. S., et al., Mol. Endocrinol. 15, 1370-1380 (2001)
8) Oyama, T., et al., Cancer Res. 58, 2876-2880 (1998)
9) Bartkova, J., et al., Cancer Res. 56, 5475-5483 (1996)
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|